Biotalys NV reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was EUR 22.73 million compared to EUR 16.93 million a year ago. Basic loss per share from continuing operations was EUR 0.74.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.02 EUR | +7.86% | -0.66% | -35.33% |
05-02 | Biotalys Starts Field Trials for Second Biofungicide | CI |
04-30 | Biotalys Announces Board and Committee Changes | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-35.33% | 97.4M | |
-1.72% | 7.17B | |
+12.78% | 3.37B | |
+10.89% | 863M | |
+3.05% | 384M | |
+9.60% | 287M | |
+263.64% | 93.1M |
- Stock Market
- Equities
- BTLS Stock
- News Biotalys NV
- Biotalys NV Reports Earnings Results for the Full Year Ended December 31, 2022